HBI 2024 |

How are providers assessing and extracting value from their data? How do you best analyse it to improve outcomes and patient experience? And how do you best analyse it to optimise workflow and patient throughput? Three casestudies demonstrate what is possible and the pitfalls to avoid.

Speakers include:

Wolfgang Hofmann, Group head technology and innovation, Fresenius Group
Wolfgang will share how Fresenius is approaching digitalisation, implementing generative AI and moving to the cloud in the complexity of a large organisational structure.

Nuclear medicine long had its place in the diagnosis and treatment of disease, primarily in cardiology and oncology. Today, the nuclear medicine market is at an inflection point, as the rise of theragnostics and the advent of novel products is expected to nearly quadruple the size of the market in the next 10 years from ~$7bn to $25+bn by 2033. The enormous growth in the field is driven by continued radiopharmaceutical funding where 250+ trials are currently being conducted and by trial funding increasing ~45%+ p.a. between 2019 and 2022. This session features perspectives from a provider, radiopharmaceutical group and OEM on how this is accelerating growth, shaping the market and discussing the medium and long-term obstacles.

Moderation and market overview: Ian Poburenny, Director, Healthcare, Rothschild & Co

The unexpected and dramatic fall of telehealth startup Babylon in 2023 highlighted the fragility of the telemedicine model. Despite strong revenue, profitability and therefore sustainability is put into question. So, what is the right business model for telemedicine and what lessons have been learnt from Babylon and other telemedicine provider troubles. This session features CEOs of a telemedicine provider, primary care group and pharmacy group to share their models, discuss reimbursement, growth and how to make the telemedicine model profitable.

This sector is still reeling from the effects of the pandemic and a number of subsequent scandals made ever harder with rising costs and labour shortages. What are the new innovative care models that are being deployed? How can digital transformation and flexible employment models make a difference?

Speakers include:

Marja Aarnio-Isohanni, Operating Partner, GSquare

As demand rises and capacity remains a challenge for the public sector globally, patients are turning to self-pay and private medical insurance. With this patients have shifted to become consumers, demanding speed, more control over their care pathway and a return on their own investment; increased quality and outcomes. This session features three CEOs who outline how consumerisation has led to new business models, strong brands and long-term patient engagement including how to best building really sticky apps.

Speakers include:

Justin Ash, CEO, Spire
Charlie Bullock, CEO, Scan.com

With an ever growing workforce shortage and labour costs rising at unsustainable rates, what can be done now to stem the flow? Maintaining the pipeline of staff training is important, but addressing inefficient processes, elminating waste and harnessing automation and new working models to boost productivity can make a huge impact. This keynote looks at efficiency and productivity gains using case studies and real data.

With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively? Is there a threat from blood testing start-ups that are like Theranos, but work? This session features three laboratory diagnostic CEOs who share their approaches to growth.

A consumer outpatient model just like dental, aesthetics or ophthalmology, vet services is seeing strong investor interest. With the emergence of big national and international platforms, how does this sector handle workforce challenges, cost pressure, funding models and digital transformation? What can be learned from its retail-orientated model, adding new over the counter products and services? This session features three vet services groups of different scale who share their strategies for growth.

Ophthalmology continues to be a big area of investor interest with considerable scope for consolidation. Governments are increasingly outsourcing cataract operations, and the sector is starting to unlock the potential for multifocal lenses in middle age. In this session providers and medtech discuss new models in care delivery, the impact of smart equipment and digital disruption.

Speakers include:

Volker Wendel, CEO, Sanoptis